SEI Investments’s Tonix Pharmaceuticals TNXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$559K Buy
57,360
+20,888
+57% +$247K ﹤0.01% 2588
2026
Q2
$465K Buy
36,472
+25,501
+232% +$329K ﹤0.01% 2672
2026
Q1
$151K Hold
10,971
– – ﹤0.01% 3021
2025
Q4
$171K Buy
+10,971
New +$202K ﹤0.01% 2937

Other funds holding TNXP

SEI Investments's TNXP Position: Q3 2026 in Review

SEI Investments increased its Tonix Pharmaceuticals (TNXP) stake by 57% in Q3 2026, buying an estimated $247K and bringing the position to 57,360 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

SEI Investments first reported a position in TNXP in Q4 2025 and has held it in 4 quarters since. 76 funds tracked by Wall St. Rank hold TNXP as of Q3 2026.

  • SEI Investments held 57,360 shares of Tonix Pharmaceuticals worth $559K as of Q3 2026.
  • SEI Investments bought 20,888 Tonix Pharmaceuticals shares in Q3 2026, an estimated $247K.
  • Tonix Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2588 holding.
  • SEI Investments first reported a position in Tonix Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 76 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.